세계의 치과 연부조직 재생 시장 예측(-2029년) : 제품 유형별, 용도별, 최종사용자별, 지역별

The dental soft-tissue regeneration market is projected to reach USD 0.54 billion by 2029 from USD 0.37 billion in 2024, at a CAGR of 7.8% during the forecast period. The dental soft-tissue regeneration market has had strong growth due to a number of factors such as the rising incidences of periodontal diseases, increasing awareness of oral health, and growing trend of cosmetic dentistry. Moreover, the initiatives to develop healthcare infrastructure in underdeveloped regions demand more dental treatments and related products. Additionally, the advancements in regenerative biomaterials has also played a major role in the market's growth.

"By product type, collagen-based segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on the product type, the collagen-based membrane segment is expected to dominate the the dental soft-tissue regeneration market due to several factors. Collagen-based membranes acts as barriers to guide tissue growth, where they support the healing of periodontal defects and implant-based defects. Moreover, these membrnes have the ability to integrate with surrounding tissues and supports the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials further support the growth of this market.

"By application, implantology segment is expected to have the largest market share in the dental soft-tissue regeneration market."

Based on application, the implantology segment is expected to hold the largest market share in the dental soft-tissue regeneration market due to the growing aging population, increasing awareness of oral health and increasing demand for cosmetic dentistry. Moreover, to promote healing in peri-implant soft tissues, products like collagen membranes, soft tissue grafts, and advanced bioactive materials are increasingly used. Additionally, innovations in soft tissue regenerative solutions, and increasing awareness of dental aesthetics further support the growth of dental soft-tissue regeneration market.

"By region, North American region is expected to have the largest market share in the dental soft-tissue regeneration market."

North America to register for the highest share of the dental soft-tissue regeneration market during the forecast period due to several factors. The presence of advanced healthcare infrastructure, and high health expenditure rates drive the demand for advanced dental care treatments in this region. Moreover, the significant rise in the geriatric population, which is more prone to periodontal diseases, covers the majority of the treatments required in North America. Favorable government policies, and reimbursement frameworks for dental care treatments, along with a high dental insurance coverage among the patients, supports them toward getting advance dental care treatments. Additonaly, the ongoing research and development in dental technologies and biomaterials, also support this expansion in this region.

A breakdown of the primary participants (supply-side) for the dental soft-tissue regeneration market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-45%, Director Level-35%, and Others-20%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), Dentsply Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), Bego GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

Research Coverage:

The report analyzes the dental soft-tissue regeneration market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental soft-tissue regeneration market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services, and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries) and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
• Market Penetration: It includes extensive information on products offered by the major players in the global the dental soft-tissue regeneration market. The report includes various segments in product type, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the dental soft-tissue regeneration market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 SEGMENTS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary research
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Objectives of primary research
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.3 TOP-DOWN APPROACH: SUPPLY-SIDE ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DENTAL SOFT-TISSUE REGENERATION MARKET OVERVIEW
• 4.2 ASIA PACIFIC: DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE AND COUNTRY (2023)
• 4.3 DENTAL SOFT-TISSUE REGENERATION MARKET: REGIONAL MIX
• 4.4 DENTAL SOFT-TISSUE REGENERATION MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 4.5 DENTAL SOFT-TISSUE REGENERATION MARKET: EMERGING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of periodontal diseases
    • 5.2.1.2 Growing demand for cosmetic dentistry
    • 5.2.1.3 Rising popularity of biodegradable biomaterials
    • 5.2.1.4 Advancements in regenerative technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Inadequate dental insurance reimbursements and high cost of dental services
    • 5.2.2.2 Dearth of trained dental practitioners
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Introduction of dental service organizations and consolidation of dental practices
    • 5.2.3.2 Growth opportunities in emerging economies
    • 5.2.3.3 Increasing popularity of dental tourism in emerging countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Pricing pressure and increased market competition
    • 5.2.4.2 Stringent regulatory environment
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADVANCEMENTS IN DIGITAL DENTISTRY
  • 5.3.2 INCREASED NUMBER OF MINIMALLY INVASIVE DENTAL PROCEDURES
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 TECHNOLOGY ANALYSIS
  • 5.5.1 KEY TECHNOLOGIES
    • 5.5.1.1 3D bioprinting
  • 5.5.2 COMPLEMENTARY TECHNOLOGIES
    • 5.5.2.1 Laser-assisted technology
  • 5.5.3 ADJACENT TECHNOLOGIES
    • 5.5.3.1 Advanced biomaterials
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.7.2 KEY BUYING CRITERIA
• 5.8 REGULATORY LANDSCAPE ANALYSIS
  • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.2 REGULATORY FRAMEWORK
    • 5.8.2.1 North America
      • 5.8.2.1.1 US
    • 5.8.2.2 Europe
    • 5.8.2.3 Asia Pacific
      • 5.8.2.3.1 India
      • 5.8.2.3.2 China
      • 5.8.2.3.3 Japan
• 5.9 PATENT ANALYSIS
  • 5.9.1 KEY PATENTS GRANTED
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 300640
  • 5.10.2 EXPORT DATA FOR HS CODE 300640
• 5.11 PRICING ANALYSIS
  • 5.11.1 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY KEY PLAYER
  • 5.11.2 INDICATIVE SELLING PRICE OF DENTAL SOFT-TISSUE REGENERATION PRODUCTS, BY REGION
• 5.12 KEY CONFERENCES & EVENTS, 2024-2025
• 5.13 UNMET NEEDS/END-USER EXPECTATIONS
• 5.14 ADJACENT MARKET ANALYSIS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
• 5.17 SUPPLY CHAIN ANALYSIS
• 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.19 INVESTMENT & FUNDING SCENARIO
• 5.20 REIMBURSEMENT SCENARIO ANALYSIS
• 5.21 IMPACT OF AI/GEN AI ON DENTAL SOFT-TISSUE REGENERATION MARKET
• 5.22 PREVALENCE OF GINGIVAL DISEASES, BY KEY REGION, 2023
• 5.23 TOTAL NUMBER OF SURGERIES, BY KEY REGION, 2023

6 DENTAL SOFT-TISSUE REGENERATION MARKET, BY PRODUCT TYPE

• 6.1 INTRODUCTION
  • 6.1.1 COLLAGEN-BASED MEMBRANES
    • 6.1.1.1 Potential to enhance dental tissue regeneration to drive market
  • 6.1.2 AUTOGRAFTS
    • 6.1.2.1 High compatibility and reduced infection risks to drive market
  • 6.1.3 SYNTHETIC BIOMATERIALS
    • 6.1.3.1 Technological advancements in biomaterials to fuel market growth
  • 6.1.4 OTHER PRODUCTS

7 DENTAL SOFT-TISSUE REGENERATION MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • 7.1.1 IMPLANTOLOGY
    • 7.1.1.1 Growing need for implant-supported soft-tissue regeneration to drive market
  • 7.1.2 PERIODONTOLOGY
    • 7.1.2.1 Increasing prevalence of periodontal diseases to favor market growth
  • 7.1.3 OTHER APPLICATIONS

8 DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 DENTAL HOSPITALS
  • 8.2.1 GROWING AWARENESS OF ORAL HEALTH TO BOOST MARKET
• 8.3 DSOS & INDEPENDENT CLINICS
  • 8.3.1 ADVANCEMENTS IN DENTAL CARE TO DRIVE DEMAND
• 8.4 ACADEMIC & RESEARCH INSTITUTES
  • 8.4.1 DEVELOPMENT OF ADVANCED DENTAL SOLUTIONS TO BOOST MARKET GROWTH

9 DENTAL SOFT-TISSUE REGENERATION MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American dental soft-tissue regeneration market
  • 9.2.3 CANADA
    • 9.2.3.1 Stringent regulatory compliance to support market growth in Canada
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to dominate dental soft-tissue regeneration market in Europe
  • 9.3.3 UK
    • 9.3.3.1 Rising number of geriatric patients to drive market
  • 9.3.4 FRANCE
    • 9.3.4.1 Well-established healthcare system to drive market
  • 9.3.5 SPAIN
    • 9.3.5.1 Government initiatives for providing dental coverage to support market growth
  • 9.3.6 ITALY
    • 9.3.6.1 Growing penetration of dental products to drive market growth
  • 9.3.7 REST OF EUROPE (ROE)
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 JAPAN
    • 9.4.2.1 Rising geriatric population to support market growth
  • 9.4.3 CHINA
    • 9.4.3.1 Growing geriatric population and increasing per capita income to support market growth
  • 9.4.4 INDIA
    • 9.4.4.1 Growing dental care sector to fuel market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Growing healthcare expenditure to aid market growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Well-developed healthcare sector to drive market
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Brazil to hold largest share in Latin American market
  • 9.5.3 MEXICO
    • 9.5.3.1 Increasing healthcare infrastructure to propel market growth
  • 9.5.4 ARGENTINA
    • 9.5.4.1 Advancements in dental technology to spur growth
  • 9.5.5 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH
  • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
• 9.7 GCC COUNTRIES
  • 9.7.1 RISING DISPOSABLE INCOMES TO DRIVE MARKET GROWTH
  • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL SOFT-TISSUE REGENERATION MARKET
• 10.3 REVENUE ANALYSIS, 2019-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 BRAND/PRODUCT COMPARISON
• 10.8 R&D EXPENDITURE OF KEY PLAYERS
• 10.9 COMPANY VALUATION & FINANCIAL METRICS
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES
  • 10.10.2 DEALS
  • 10.10.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 GEISTLICH PHARMA AG
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
      • 11.1.1.3.2 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 INSTITUT STRAUMANN AG
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 MnM view
      • 11.1.2.3.1 Right to win
      • 11.1.2.3.2 Strategic choices
      • 11.1.2.3.3 Weaknesses & competitive threats
  • 11.1.3 HENRY SCHEIN, INC.
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 ENVISTA
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
  • 11.1.5 ZIMVIE INC.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 DENTSPLY SIRONA INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Right to win
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses & competitive threats
  • 11.1.7 ABBVIE INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Expansions
  • 11.1.8 ADVANCED MEDICAL SOLUTIONS GROUP PLC
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
  • 11.1.9 TISSUE REGENIX
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 SEPTODONT HOLDING
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
  • 11.1.11 MEDICAL CONSULT IMPLANTS GMBH
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
  • 11.1.12 MECCELLIS BIOTECH
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 REGEDENT AG
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 REGENITY
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Deals
  • 11.1.15 AD SURGICAL
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 LIFENET HEALTH
  • 11.2.2 B. & B. DENTAL S.R.L.
  • 11.2.3 ALPHA-BIO TEC. LTD.
  • 11.2.4 LASAK S.R.O.
  • 11.2.5 KEYSTONE DENTAL GROUP
  • 11.2.6 NEOSS AG
  • 11.2.7 BEGO GMBH & CO. KG
  • 11.2.8 BIOTECH DENTAL
  • 11.2.9 SAMYANG HOLDINGS CORPORATION
  • 11.2.10 RTI SURGICAL

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS